Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials

Int J Womens Dermatol. 2024 Aug 21;10(3):e171. doi: 10.1097/JW9.0000000000000171. eCollection 2024 Oct.

Simon J Gunter¹, Martina L Porter^{2

3}, Alexa B Kimball^{2

3}

¹ Harvard Medical School, Boston, Massachusetts.
² Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
³ Department of Dermatology, Harvard Medical School, Boston, Massachusetts.

No abstract available